Search Within

Advanced Practice Providers

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (126)
  2. Journal Article (123)
  3. Research Letter (6)
  4. Correspondence (1)
  5. Review (1)
Groups
  1. Biostatistics Service (257)
  2. Epidemiology and Biostatistics (257)
  3. Nursing (209)
  4. Department of Medicine (200)
  5. Survivorship Research (151)
  6. Hematologic Malignancies, Division of (124)

More Groups

People
  1. Sean Devlin (68)
  2. Sergio Giralt (57)
  3. Miguel-Angel Perales (52)
  4. Gunjan Shah (42)
  5. Craig Sauter (32)
  6. Michael Scordo (31)

More People

Years
  1. 2025 (3)
  2. 2024 (15)
  3. 2023 (16)
  4. 2022 (18)
  5. 2021 (24)
  6. 2020 (24)

More Years

Publications
  1. Journal of Clinical Oncology (46)
  2. Blood (44)
  3. Biology of Blood and Marrow Transplantation (19)
  4. Annals of Surgical Oncology (8)
  5. Bone Marrow Transplantation (8)
  6. Cancer (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (52)
  2. American Society of Hematology (49)
  3. Elsevier Inc. (42)
  4. American Association for Cancer Research (13)
  5. Nature Publishing Group (13)
  6. Springer (13)

More Publishers

Results (257)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Journal Article

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K. V.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Discharge prescribing of enteral opioids in opioid naïve patients following non-surgical intensive care: A retrospective cohort study
    Journal Article

    Tollinche, L. E.; Seier, K. P.; Yang, G.; Tan, K. S.; Tayban, Y. D.; Pastores, S. M.; Yeoh, C. B.; Karamchandani, K.
    Journal of Critical Care (2022)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax in chronic lymphocytic leukemia: Early MRD kinetics define a high-risk patient cohort with delayed bone marrow undetectable MRD and earlier post-treatment MRD recurrence
    Meeting Abstract

    Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E. P.; Barnes, J. A.; Hamilton, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Timing and immune status after cellular therapies predict response to COVID-19 vaccines
    Meeting Abstract

    Tamari, R.; Politikos, I.; Knorr, D.; Vardhana, S.; Young, J.; Marcello, L.; Doddi, S.; Devlin, S. M.; Ramanathan, L.; Pessin, M. S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies
    Meeting Abstract

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Preliminary safety and efficacy from a multicenter, investigator-initiated phase II study in untreated TP53 mutant mantle cell lymphoma with zanubrutinib, obinutuzumab, and venetoclax (BOVen)
    Meeting Abstract

    Kumar, A.; Soumerai, J. D.; Abramson, J. S.; Batlevi, C. L.; Chadha, P.; Dogan, A.; Falchi, L.; Flaherty, K.; Friedman, C.; Grieve, C.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Journal Article

    Bewersdorf, J. P.; Derkach, A.; Gowda, L.; Menghrajani, K.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
    Research Letter

    Kozak, K. E.; Ouyang, L.; Derkach, A.; Sherman, A.; McCall, S. J.; Famulare, C.; Chervin, J.; Daley, R. J.; Morjaria, S.; Mauro, M. J.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; Rivière, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save